Paul Tudor Jones Ultragenyx Pharmaceutical Inc. Transaction History

Tudor Investment Corp Et Al

$26.8 Billion
Q3 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 54,496 shares of RARE stock, worth $2.37 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

54,496

Previous 34,563 57.67%

Holding current value

$2.37 Million

Previous $1.42 Million 113.17%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$40.21 - $59.36 $801,505 - $1.18 Million	19,933 Added 57.67%	54,496 $3.03 Million
Q2 2024 Aug 14, 2024	BUY	$37.42 - $51.61 $1.29 Million - $1.78 Million	34,563 New	34,563 $1.42 Million
Q2 2023 Aug 14, 2023	SELL	$37.35 - $52.15 $20,467 - $28,578	-548 Reduced 1.46%	36,919 $1.7 Million
Q1 2023 May 15, 2023	BUY	$36.99 - $48.71 $1.39 Million - $1.83 Million	37,467 New	37,467 $1.5 Million
Q3 2022 Nov 14, 2022	BUY	$39.96 - $66.14 $772,746 - $1.28 Million	19,338 Added 117.98%	35,729 $1.48 Million
Q2 2022 Aug 15, 2022	BUY	$45.8 - $85.4 $750,707 - $1.4 Million	16,391 New	16,391 $978,000
Q1 2022 May 16, 2022	SELL	$62.2 - $84.4 $275,546 - $373,892	-4,430 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$73.71 - $87.86 $2.31 Million - $2.76 Million	-31,359 Reduced 87.62%	4,430 $373,000
Q3 2021 Nov 15, 2021	BUY	$77.92 - $102.4 $1.55 Million - $2.04 Million	19,932 Added 125.7%	35,789 $3.23 Million
Q2 2021 Aug 16, 2021	BUY	$92.19 - $115.71 $1.46 Million - $1.83 Million	15,857 New	15,857 $1.51 Million
Q1 2021 May 17, 2021	SELL	$106.9 - $167.73 $1.89 Million - $2.97 Million	-17,712 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$84.4 - $177.39 $145,758 - $306,352	1,727 Added 10.8%	17,712 $2.45 Million
Q3 2020 Nov 16, 2020	BUY	$72.98 - $90.0 $388,107 - $478,620	5,318 Added 49.85%	15,985 $1.31 Million
Q2 2020 Aug 14, 2020	BUY	$46.91 - $78.22 $500,388 - $834,372	10,667 New	10,667 $834,000
Q4 2019 Feb 14, 2020	SELL	$36.08 - $45.83 $512,841 - $651,427	-14,214 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$42.5 - $63.11 $604,095 - $897,045	14,214 New	14,214 $608,000

Others Institutions Holding RARE

# of Institutions

325

Shares Held

85.6M

Call Options Held

520K

Put Options Held

406K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.04B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account